CPhI Japan Webinar - StevanatoGroup
search img
CPhI Japan Webinar - StevanatoGroup
Home - Integrated solutions for pharma & healthcare - StevanatoGroup > News & Events - StevanatoGroup > Events - StevanatoGroup > CPhI Japan Webinar - StevanatoGroup
page-wrapper
2020-11-20 00:00:00 2020-11-20 00:00:00
Virtual Event
45.613902,11.99691
n.a.
CPhI Japan Webinar
SPEECH

CPhI Japan Webinar

20 November 2020

Virtual Event

Curious about biologics’ future market trends? Discover how Stevanato Group solutions can support the biologic drug development by joining our speech during CPhI Japan Webinar!

SG Alba SG Nexa SG Fina
SG Alba SG Nexa SG Fina

Speech:

Friday, November 20th – 2.15 to 2.45 pm (JST)

Kazunari Hattori - Regulatory affairs 

"Optimized Packaging Solutions for Biologic Drug Products"

By 2025 biologics are expected to be about 34% of the overall drug market versus about 23% registered in 2015: this progressive growth of biologics, including biosimilars, is driving the need for new container platforms.

This means that the primary packaging containers industry must support pharma companies with flexible solutions to cut TCO and to reduce the time-to-market starting from the early development stage.

Through Nexa® and Alba® glass containers devised for biologics and our ready to use platform, EZ-fill®, Stevanato Group can streamline the biologic drug development, improving operational efficiency, quality, safety and time to market.

In this presentation you will learn about our quality levels, the advantages of ready to use components, formats and capabilities.

 

Get more information about our high-quality glass primary packaging by clicking here: 

SG Alba® and SG Nexa® Glass Containers